Leveraging the Immunologic Dysfunction in Bladder Cancer Through Combination Systemic Therapy

Leveraging the Immunologic Dysfunction in Bladder Cancer Through Combination Systemic Therapy is organized by Med Learning Group and will be held from Jan 22, 2019 - Jan 22, 2020.This CME Conference has been approved for a maximum of 1.0 AMA Category 1 Credit(s)™.

Target Audience:
This activity is designed to meet the educational needs of urologists, medical oncologists, and other health care providers involved in the referral and treatment of patients with advanced and metastatic Bladder Cancer.

Description:
This live activity will cover the treatment and management of patients with bladder cancer.

Learning Objectives:
On completing the program, attendees should be able to:
• Review the role of the immune system in the pathogenesis of patients with bladder cancer
• Describe the immunotherapy clinical trial data in the systemic treatment of patients with advanced or metastatic bladder cancer
• Discuss the personalization of care that incorporates shared decision-making in the management of patients with advanced or metastatic Bladder Cancer

 Additional details will be posted as soon as they are available.